Table 1 Characteristics of studies included in the systematic review and meta-analysis of the magnitude of chronic kidney disease among type 2 Dm patients worldwide
Authors/ publication year | Region | Study design | Study setting | Sample size | Prevalence of CKD (%) | Quality assessment based on JBI |
|---|---|---|---|---|---|---|
Anunya Pradidthaprecha, et,al (2021)[50] | Thailand | retrospective | hospital based | 3,465 | 29.70% | 9 |
Junlin Zhang etal(2022)[39] | USA | retrospective | hospital based | 2720 | 35.06% | 8 |
Janjira Jitraknatee etal/2020[49] | Thailand | cross-sectional | primary care | 1,096 | 24.40% | 8 |
Sojib Bin Zaman etal/2018[51] | Thailand | retrospective | district hospital | 3,580 | 23.26% | 6 |
Ruth Usó-Talamantes etal.2021[48] | Spain | cross-sectional | Spanish Health District | 14,935 | 33.80% | 9 |
Juan,MartÃnez Candelaa.etal/2018[47] | Spain | cross-sectional | Primary Care | 939 | 37.20% | 8 |
Zaher Nazzal.etal/2020[42] | Palestine | cross-sectional | PHC clinics | 385 | 23.60% | 7 |
Ruth Sim etal./2023 [41] | malasiya | cross-sectional | two tertiary hospitals | 1992 | 15% | 6 |
KÃ¥re I. Birkeland MD etal/2020[52] | Europe and Asia | cross-sectional | population-based study | 1, 177 896 | 36% | 6 |
Medina Abdela Ahmed etal/2022[33] | Ethiopia | retrospective | Referral hospitals | 415 | 10.80% | 8 |
Petter Bjornstad, M.D.,etal/2021[43] | USA | prospective | Hospital based | 500 | 54.80% | 6 |
 S Al-Shamsi et al. /2018[36] | United Arab Emirates | retrospective | two public hospitals | 251 | 37.70% | 7 |
Lin Yang etal/2018[46] | China | prospective | primary care setting | 31,574 | 29.70% | 9 |
Jiayu Duan1etal/2019[45] | China | prospective | rural districts | 2710 | 35.50% | Â |
Shewaneh Damtie1etal/2018[34] | Ethiopia | cross-sectional | hospital based | 119 | 3.751 | 8 |
Elliot K. Tannor, MD et al. /2019[35] | Ghana | cross-sectional | hospital based | 348 | 16.10% | 8 |
Antonio González-Pérez etal/2019[40] | UK | Cohort | hospital based | 109,365 | 26% | 7 |
Louisa Sukkar etal/2020[37] | Australia | prospective | population-based | 9,313 | 22.60% | 6 |
Peter Bramlage1 et al. 2019[38] | Germany | cross-sectional | hospital based | 343,675 | 50% | 9 |
Darren K. McGuire MD etal/ 2023 [44] | USA | randomized controlled | hospital based | 9650 | 42.3% | 7 |